{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:36:05Z","timestamp":1788582965607,"version":"build-2803163510"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[1993,3]]},"DOI":"10.1007\/bf01000528","type":"journal-article","created":{"date-parts":[[2005,1,19]],"date-time":"2005-01-19T05:38:59Z","timestamp":1106113139000},"page":"1-44","source":"Crossref","is-referenced-by-count":60,"title":["Tryptamine: A metabolite of tryptophan implicated in various neuropsychiatric disorders"],"prefix":"10.1007","volume":"8","author":[{"given":"Darrell D.","family":"Mousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.172.3988.1159","volume":"172","author":"G.K. Aghajanian","year":"1971","unstructured":"Aghajanian, G.K., and Asher, I.M. (1971). Histochemical fluorescence of raph\u00e9 neurones: Selective enhancement by tryptophan.Science 172: 1159?1161.","journal-title":"Science"},{"key":"CR2","first-page":"619","volume":"1","author":"G.K. Aghajanian","year":"1975","unstructured":"Aghajanian, G.K., and Haigler, H.J. (1975). Hallucinogenic indoleamines: preferential action upon presynaptic serotonin receptors.Psychopharmacol. Comm. 1: 619?629.","journal-title":"Psychopharmacol. Comm."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1600-0773.1980.tb02459.x","volume":"46","author":"M.M. Airaksinen","year":"1980","unstructured":"Airaksinen, M.M., Svensk, H., Tuomisto, J., and Komulainen, H. (1980). Tetrahydro-?-carbolines and corresponding tryptamines:In vitro inhibition of serotonin and dopamine uptake by human blood platelets.Acta Pharmacol. Toxicol. 46: 308?313.","journal-title":"Acta Pharmacol. Toxicol."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0306-4522(86)90241-1","volume":"17","author":"C.A. Altar","year":"1986","unstructured":"Altar, C.A., Wasley, A.M., and Martin, L.L. (1986). Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain.Neuroscience 17: 263?273.","journal-title":"Neuroscience"},{"key":"CR5","first-page":"1427","volume":"19","author":"G.M. Anderson","year":"1984","unstructured":"Anderson, G.M., Gerner, R.H., Cohen, D.J., and Fairbanks, L. (1984). Central tryptamine turnover in depression, schizophrenia and anorexia: Measurement of indoleacetic acid in cerebrospinal fluid.Biol. Psychiat. 19: 1427?1435.","journal-title":"Biol. Psychiat."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02211951","volume":"18","author":"G.M. Anderson","year":"1988","unstructured":"Anderson, G.M., Ross, D.L., Klykylo, W., Feibel, F.C., and Cohen, D.J. (1988). Cerebrospinal fluid indoleacetic acid in autistic subjects.J. Autism Develop. Disorders 18: 259?262.","journal-title":"J. Autism Develop. Disorders"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-3908(82)90212-X","volume":"21","author":"C.D. Andrews","year":"1982","unstructured":"Andrews, C.D., Fernando, J.C.R., and Curzon, G. (1982). Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses.Neuropharmacol. 21: 63?68.","journal-title":"Neuropharmacol."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0024-3205(70)90127-X","volume":"9","author":"F. Anton-Tay","year":"1970","unstructured":"Anton-Tay, F., Sepulveda, J., and Gonzalez, S. (1970). Increase of brain pyridoxal phosphokinase activity following melatonin administration.Life Sci. 9: 1283?1288.","journal-title":"Life Sci."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-9861(54)90115-0","volume":"52","author":"M.D. Armstrong","year":"1954","unstructured":"Armstrong, M.D., and Robinson, K.S. (1954). On the excretion of indole derivatives in phenylketonuria.Arch. Biochem. Biophys. 52: 287.","journal-title":"Arch. Biochem. Biophys."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0003-2697(79)90651-1","volume":"92","author":"F. Artigas","year":"1979","unstructured":"Artigas, F., and Gelpi, E. (1979). A new mass fragmentographic method for the simultaneous analysis of tryptophan, tryptamine, indole-3-acetic acid, serotonin and 5-hydroxyindole-3-acetic acid in the same sample of rat brain.Anal. Biochem. 92: 233?242.","journal-title":"Anal. Biochem."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0028-3908(80)90183-5","volume":"19","author":"C.K. Atterwill","year":"1980","unstructured":"Atterwill, C.K., and Green, A.R. (1980). Responses of developing rats to L-tryptophan and an MAOI. I. Monitoring changes in behaviour, brain 5-HT and tryptophan.Neuropharmacol. 19: 325?335.","journal-title":"Neuropharmacol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0003-9861(62)90220-5","volume":"98","author":"J. Awapara","year":"1962","unstructured":"Awapara, J., Sandman, R.P., and Hanly, C. (1962). Activation of DOPA decarboxylase by pyridoxal phosphate.Arch. Biochem. Biophys. 98: 520?525.","journal-title":"Arch. Biochem. Biophys."},{"key":"CR13","first-page":"28","volume":"138","author":"J. Axelrod","year":"1962","unstructured":"Axelrod, J. (1962). The enzymatic N-methylation of serotonin and other amines.J. Pharmacol. Exp. Therap. 138: 28?33.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0364-7722(81)90050-3","volume":"5","author":"G.B. Baker","year":"1981","unstructured":"Baker, G.B., and Yasensky, D.L. (1981). Interactions of trace amines with dopamine in rat striatum.Prog. Neuro-Psychopharmacol. 5: 577?580.","journal-title":"Prog. Neuro-Psychopharmacol."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4612-5010-4_34","volume-title":"Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects","author":"G.B. Baker","year":"1985","unstructured":"Baker, G.B., Coutts, R.T., Yeung, J.M., Hampson, D.R., McIntosh, G.J.A., and McIntosh, M. (1985). Chronic administration of monoamine oxidase inhibitors: Basic and clinical investigations. In Boulton A.A., Maitre L., Bieck P.R. and Riederer P. (eds) Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects, Humana Press, Clifton, N.J., pp. 317?328."},{"key":"CR16","first-page":"167","volume":"23","author":"G.B. Baker","year":"1980","unstructured":"Baker, G.B., Hiob, L.E., Martin, I.L., Mitchell, P.R., and Dewhurst, W.G. (1980b). Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatumin vitro.Proc. West. Pharmacol. Soc. 23: 167?170.","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"CR17","first-page":"151P","volume":"61","author":"G.B. Baker","year":"1977","unstructured":"Baker, G.B., Martin, I.L., and Mitchell, P.R. (1977). The effects of some indolalkylamines on the uptake and release of 5-hydroxytryptamine in rat striatum.Brit. J. Pharmacol. 61: 151P?152P.","journal-title":"Brit. J. Pharmacol."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/245025a0","volume":"245","author":"R.J. Baldessarini","year":"1973","unstructured":"Baldessarini, R.J., and Fischer, J.E. (1973). Serotonin metabolism in rat brain after surgical diversion of the portal venous system.Nature 245: 25?27.","journal-title":"Nature"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archpsyc.1974.01760180100013","volume":"174","author":"J.D. Barchas","year":"1974","unstructured":"Barchas, J.D., Elliot, G.R., DoAmaral, J., Erdelyi, E., O'Connor, S. Bowden, M., Brodie, H.K.H., Berger, P.A., Renson, J., and Wyatt, R.J. (1974). Tryptolines: Formation from tryptamine and 5MTHF by human platelets.Arch. Gen. Psychiat. 174: 862.","journal-title":"Arch. Gen. Psychiat."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-2952(80)90169-0","volume":"29","author":"S.A. Barker","year":"1980","unstructured":"Barker, S.A., Monti, A.J. and Christian, S.T. (1980). Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates.Biochem. Pharmacol. 29: 1049?1057.","journal-title":"Biochem. Pharmacol."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(56)91914-6","volume":"271","author":"D.N. Baron","year":"1956","unstructured":"Baron, D.N., Dent, C.E., Harris, H., Hart, E.W., and Jepson, J.B. (1956). Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features.Lancet 271: 421.","journal-title":"Lancet"},{"key":"CR22","first-page":"273","volume":"12","author":"J.P. Bennett","year":"1976","unstructured":"Bennett, J.P., and Snyder, S.H. (1976). Serotonin and lysergic acid diethylamide in rat brain membranes: Relationship to postsynaptic serotonin receptors.Mol. Pharmacol. 12: 273?289.","journal-title":"Mol. Pharmacol."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.1978.tb08649.x","volume":"64","author":"T. Bennett","year":"1978","unstructured":"Bennett, T., and Gardiner, S.M. (1978). Corticosteroid involvement in the changes in noradrenergic responsiveness of tissues from rats made hypertensive by short-term isolation.Br. J. Pharmacol. 64: 129?136.","journal-title":"Br. J. Pharmacol."},{"key":"CR24","first-page":"1131","volume-title":"Psychotherapeutic Drugs, Part II: Applications","author":"M.H. Bickel","year":"1977","unstructured":"Bickel, M.H. (1977). Imipramine series. In Psychotherapeutic Drugs, Part II: Applications Usdin E. and Forrest I.S. (eds), Marcel Dekker, Inc., New York, pp. 1131?1172."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-4612-5312-9_45","volume-title":"Neurobiology of Trace Amines","author":"P.R. Bieck","year":"1984","unstructured":"Bieck, P.R., Nilsson, E., Schick, C., Waldmeier, P.C., and Lauber, J. (1984). Urinary excretion of tryptamine in comparison to normetanephrine and ?-phenylethylamine in human volunteers after subchronic treatment with different monoamine oxidase inhibitors. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds) Neurobiology of Trace Amines, Clifton, N.J., Humana Press, pp. 525?539."},{"key":"CR26","first-page":"87","volume":"15","author":"A. Bj\u00f6rklund","year":"1976","unstructured":"Bj\u00f6rklund, A., Axelsson, S., and Falck, B. (1976). Intraneuronal indoleamines in the central nervous system.Adv. Biochem. Psychopharmacol. 15: 87?94.","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"CR27","first-page":"525","volume":"175","author":"A. Bj\u00f6rklund","year":"1970","unstructured":"Bj\u00f6rklund, A., Falck, B., and Steveni, U. (1970). On the possible existence of a new intraneuronal monoamine in the spinal cord of the rat.J. Pharmacol. Exp. Therap. 175: 525?532.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(71)90324-6","volume":"32","author":"A. Bj\u00f6rklund","year":"1971","unstructured":"Bj\u00f6rklund, A., Falck, B., and Steveni, U. (1971). Classification of monoamine neurones in the mesencephalon: Distribution of a new monoamine neurone system.Brain Res. 32: 269?285.","journal-title":"Brain Res."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-4565(79)90012-3","volume":"4","author":"J. Bligh","year":"1979","unstructured":"Bligh, J., Silver, A., and Smith, C.A. (1979). A central excitatory serotonergic or serotonergic-like synapse on the pathway to heat production in the sheep.J. Thermal Biol. 4: 259?268.","journal-title":"J. Thermal Biol."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1476-5381.1972.tb07244.x","volume":"44","author":"G.V.R Born","year":"1972","unstructured":"Born, G.V.R, Juengjaosen, K., and Michal, F. (1972). Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.Br. J. Pharmacol. 44: 117?139.","journal-title":"Br. J. Pharmacol."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1139\/o74-045","volume":"52","author":"A.A. Boulton","year":"1974","unstructured":"Boulton, A.A., and Baker, G.B. (1974). The subcellular distribution of some monoamines following their intraventricular injection into the rat.Can. J. Biochem. 52: 288?293.","journal-title":"Can. J. Biochem."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.1975.tb04353.x","volume":"25","author":"A.A. Boulton","year":"1975","unstructured":"Boulton, A.A., and Baker, G.B. (1975). The subcellular distribution of ?-phenylethylamine, p-tyramine and tryptamine in rat brain.J. Neurochem. 25:477?481.","journal-title":"J. Neurochem."},{"key":"CR33","first-page":"189","volume-title":"Handbook of Neurochemistry, Vol. 1","author":"A.A. Boulton","year":"1982","unstructured":"Boulton A.A. and Juorio A.V. (1982). Brain trace amines. In Lajtha A. (ed.) Handbook of Neurochemistry, Vol. 1, Plenum Publishing Corp., New York, pp. 189?222."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/236076a0","volume":"236","author":"A.A. Boulton","year":"1972","unstructured":"Boulton, A.A., and Marjerrison, G.L. (1972). Effect of L-DOPA therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease.Nature 236: 76?78.","journal-title":"Nature"},{"key":"CR35","unstructured":"Bradley, P.B., Humphrey, P.P.A., and Williams, R.H. (1983). Are vascular ?D? and ?5-HT2? receptors for 5-hydroxytryptamine the same?Br. J. Pharmacol. Proc. Suppl. 79: 295P."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.1985.tb17386.x","volume":"84","author":"P.B. Bradley","year":"1985","unstructured":"Bradley, P.B., Humphrey, P.P.A., and Williams, R.H. (1985). Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors.Br. J. Pharmacol. 84: 919?925.","journal-title":"Br. J. Pharmacol."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0091-3057(85)90097-8","volume":"23","author":"J. Broadbent","year":"1985","unstructured":"Broadbent, J., and Greenshaw, A.J. (1985). Effects of quipazine and of tryptamine on self-stimulation of median raph\u00e9 nucleus and of lateral hypothalamus in rats.Pharmacol. Biochem. Behav. 23: 943?947.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"CR38","first-page":"9","volume":"116","author":"B.B. Brodie","year":"1956","unstructured":"Brodie, B.B., Pletscher, A., and Shore, P.A. (1956). Possible role of serotonin in brain function and in reserpine action.J. Pharmacol. Exp. Therap. 116: 9.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1962.01710220066009","volume":"6","author":"G.G. Brune","year":"1962","unstructured":"Brune, G.G., and Himwhich, H.E. (1962). Indole metabolites in schizophrenic patients.Arch. Gen. Psychiat. 6: 324?328.","journal-title":"Arch. Gen. Psychiat."},{"key":"CR40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF02147571","volume":"27","author":"G.G. Brune","year":"1971","unstructured":"Brune, G.G., and Pflughaupt, K.-W. (1971). Effects of L-DOPA treatments on indole metabolism in Parkinson's disease.Experientia 27: 516.","journal-title":"Experientia"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0024-3205(84)90058-4","volume":"34","author":"G. Br\u00fcning","year":"1984","unstructured":"Br\u00fcning, G., and Rommelspacher, H. (1984). High affinity [3H]tryptamine binding sites in various organs of the rat.Life Sci. 34: 1441?1446.","journal-title":"Life Sci."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1432-1033.1985.tb09272.x","volume":"153","author":"G. Br\u00fcning","year":"1985","unstructured":"Br\u00fcning, G., and Rommelspacher, H. (1985a). Solubilization of high-affinity [3H]tryptamine-binding sites from rat brain.Eur. J. Biochem. 153: 95?99.","journal-title":"Eur. J. Biochem."},{"issue":"Suppl.","key":"CR43","first-page":"S78","volume":"44","author":"G. Br\u00fcning","year":"1985","unstructured":"Br\u00fcning, G., and Rommelspacher, H. (1985b). Properties of (3H)tryptamine binding sites from rat brain.J. Neurochem. 44 (Suppl.): S78.","journal-title":"J. Neurochem."},{"key":"CR44","first-page":"227","volume":"18","author":"G. Br\u00fcning","year":"1989","unstructured":"Br\u00fcning, G., and Rommelspacher, H. (1989). Biochemical characterization of [3H]tryptamine binding sites from rat brain.Biochem. Internat. 18:227?233.","journal-title":"Biochem. Internat."},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0028-3908(82)90185-X","volume":"21","author":"C.S. Cascio","year":"1982","unstructured":"Cascio, C.S., and Kellar, K.J. (1982). Tetrahydro-beta-carbolines: Affinities for tryptamine and serotonergic binding sites.Neuropharmacol. 21: 1219?1221.","journal-title":"Neuropharmacol."},{"key":"CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(83)90264-9","volume":"95","author":"C.S. Cascio","year":"1983","unstructured":"Cascio, C.S., and Kellar, K.J. (1983). Characterization of [3H]tryptamine binding sites in brain.Eur. J. Pharmacol. 95: 31?39.","journal-title":"Eur. J. Pharmacol."},{"key":"CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(86)90646-1","volume":"120","author":"C.S. Cascio","year":"1986","unstructured":"Cascio, C.S., and Kellar, K.J. (1986). Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.Eur. J. Pharmacol. 120: 101?105.","journal-title":"Eur. J. Pharmacol."},{"key":"CR48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/07435808109045740","volume":"8","author":"A. Chan","year":"1981","unstructured":"Chan, A., and Ebadi, M. (1981). Evidence for the existence of a serotonin N-acetyltransferase inactivating substance in rat pineal gland.Endoc. Res. Commun. 8: 205?227.","journal-title":"Endoc. Res. Commun."},{"key":"CR49","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0014-2999(84)90076-1","volume":"106","author":"K.G. Charlton","year":"1984","unstructured":"Charlton, K.G., Johnson, T.D., Maurice, R.W., and Clarke, D.E. (1984). Kynuramine: High affinity for [3H]tryptamine binding sites.Eur. J. Pharmacol. 106: 661?664.","journal-title":"Eur. J. Pharmacol."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0003-9861(70)90144-X","volume":"141","author":"J.G. Christensen","year":"1970","unstructured":"Christensen, J.G., Dairman, W., and Udenfriend, S. (1970). Preparation and properties of a homogenous aromatic amino acid decarboxylase from hog kidney.Arch. Biochem. Biophys. 141: 356?357.","journal-title":"Arch. Biochem. Biophys."},{"key":"CR51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1471-4159.1987.tb05577.x","volume":"48","author":"A.I. Cohen","year":"1987","unstructured":"Cohen, A.I., and Blazynski, C. (1987). Tryptamine and some related molecules block the accumulation of a light-sensitive pool of cyclic AMP in the dark-adapted, dark-incubated mouse retina.J. Neurochem. 48: 729?737.","journal-title":"J. Neurochem."},{"key":"CR52","first-page":"277","volume":"8","author":"M.A. Collins","year":"1982","unstructured":"Collins, M.A., Dahl, K., Nijm, W. and Major, L.F. (1982). Evidence for homologous families of dopamine and serotonin condensation products in CSF from monkeys.Soc. Neurosci. 8: 277.","journal-title":"Soc. Neurosci."},{"key":"CR53","first-page":"195","volume":"234","author":"P.J. Conn","year":"1985","unstructured":"Conn, P.J., and Sanders-Bush, E. (1985). Serotonin-stimulated phosphoinositide turnover: Mediation by the S2 binding in rat cerebral cortex but not in subcortical regions.J. Pharmacol. Exp. Therap. 234: 195?203.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR54","first-page":"1237","volume":"113","author":"A. Coppen","year":"1967","unstructured":"Coppen, A. (1967). The biochemistry of affective disorders. Br. J. Pharmacol.113: 1237?1264.","journal-title":"Br. J. Pharmacol."},{"key":"CR55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1192\/bjp.111.479.993","volume":"111","author":"A. Coppen","year":"1965","unstructured":"Coppen, A., Shaw, D.M., Malleson, A., Eccleston, E., and Grundy, G. (1965). Tryptamine metabolism in depression.Br. J. Psychiat. 111: 993?998.","journal-title":"Br. J. Psychiat."},{"key":"CR56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1476-5381.1977.tb08408.x","volume":"61","author":"J.L. Costa","year":"1977","unstructured":"Costa, J.L., Murphy, D.L., and Reveille, J. (1977). Evaluation of the uptake of various amines into storage vesicles of intact human platelets.Br. J. Pharmacol. 61: 223?228.","journal-title":"Br. J. Pharmacol."},{"key":"CR57","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/0031-9422(88)80015-3","volume":"27","author":"D. Courtois","year":"1988","unstructured":"Courtois, D., Yvernel, D., Florin, B., and Petiard, V. (1988). Conversion of tryptamine to serotonin by cell suspension cultures ofPeganum harmala. Phytochem.27: 3137?3142.","journal-title":"Phytochem."},{"key":"CR58","first-page":"85","volume":"78","author":"B. Cox","year":"1982","unstructured":"Cox, B., and Ennis, C. (1982). The effects of tryptamine on serotonin release from hypothalamic slices is mediated by a cholinergic interneurone.Pharmacol. 78: 85?88.","journal-title":"Pharmacol."},{"key":"CR59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1113\/jphysiol.1983.sp014634","volume":"337","author":"B. Cox","year":"1983","unstructured":"Cox, B., Davis, A., Juxon, V., Lee, F., and Martin, D. (1983). A role for an indoleamine other than 5-hydroxytryptamine in the hypothalamic thermoregulatory pathways in the rat.J. Physiol. 337: 441?445.","journal-title":"J. Physiol."},{"key":"CR60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1476-5381.1981.tb10999.x","volume":"72","author":"B. Cox","year":"1981","unstructured":"Cox, B., Lee, T.F., and Martin, D. (1981). Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat.Br. J. Pharmacol. 72: 477?482.","journal-title":"Br. J. Pharmacol."},{"key":"CR61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/194292a0","volume":"194","author":"D.R. Curds","year":"1962","unstructured":"Curds, D.R. (1962). Action of 3-hydroxytyramine and tryptamine derivatives on spinal neurons.Nature 194: 292.","journal-title":"Nature"},{"key":"CR62","first-page":"217","volume":"18","author":"D.R. Curtis","year":"1962","unstructured":"Curtis, D.R., and Davis, R. (1962). Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat.Br. J. Pharmacol. 18: 217?246.","journal-title":"Br. J. Pharmacol."},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1471-4159.1992.tb11341.x","volume":"58","author":"H. Dabadie","year":"1992","unstructured":"Dabadie, H., Geffard, M., Charrier, M.C., Locuratolo, D., Berrier, C., and Jacquesy, J.C. (1992). First characterization of 6-hydroxytryptamine in the rat midbrain using specific antibodies.J. Neurochem. 58: 1292?1299.","journal-title":"J. Neurochem."},{"key":"CR64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-8993(90)91182-G","volume":"512","author":"H. Dabadie","year":"1990","unstructured":"Dabadie, H., Mons, N., and Geffard, M. (1990). Simultaneous detection of tryptamine and dopamine in rat substantia nigra and raph\u00e9 nuclei using specific antibodies.Brain Res. 512: 138?142.","journal-title":"Brain Res."},{"issue":"Suppl","key":"CR65","first-page":"232","volume":"62","author":"A. Dahlstr\u00f6m","year":"1964","unstructured":"Dahlstr\u00f6m, A., and Fuxe, K. (1964). Evidence for the existence of monoamine containing neurones in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons.Acta Physiol. Scand. 62 (Suppl): 232.","journal-title":"Acta Physiol. Scand."},{"key":"CR66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0006-8993(73)90418-6","volume":"49","author":"F.V. Feudis De","year":"1973","unstructured":"De Feudis, F.V., and Black, W.C. (1973). A comparison of the binding of [14C]-gamma-arninobutyric acid and [3H]acetylcholine to paniculate fractions of 4 regions of rat brain in the presence of 40 mMNaCl.Brain Res. 49: 218?222.","journal-title":"Brain Res."},{"key":"CR67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.1978.tb17290.x","volume":"64","author":"J.F.W. Deakin","year":"1978","unstructured":"Deakin, J.F.W., and Green, A.R. (1978). The effects of putative 5-HT antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.Br. J. Pharmacol. 64: 201?209.","journal-title":"Br. J. Pharmacol."},{"key":"CR68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4612-5010-4_11","volume-title":"Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects","author":"A. Delini-Stula","year":"1985","unstructured":"Delini-Stula, A., and Radeke, E. (1985). Behavioral and pharmacological characterisation of tryptamine-induced excitation syndrome in rats. In Boulton A.A., Bieck P.R., Maitre L. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects, Humana Press, Clifton, N.J., pp. 125?140."},{"key":"CR69","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1471-4159.1989.tb09145.x","volume":"52","author":"K.M. Dewar","year":"1989","unstructured":"Dewar, K.M., and Reader, T.A. (1989). Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: Role of disulfide and sulfhydryl groups.J. Neurochem. 52: 472?482.","journal-title":"J. Neurochem."},{"key":"CR70","unstructured":"Dewhurst, W.G. (1968a). Cerebral amine functions in health and disease. In Sheperd M. and Davies D.L. (eds.) Studies in Psychiatry, Oxford University Press, pp. 289?317."},{"key":"CR71","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/2181130a0","volume":"218","author":"W.G. Dewhurst","year":"1968","unstructured":"Dewhurst, W.G. (1968b). New theory of cerebral amine function and its clinical application.Nature (Land.) 218: 1130?1133.","journal-title":"Nature (Land.)"},{"key":"CR72","first-page":"705","volume":"25","author":"W.G. Dewhurst","year":"1965","unstructured":"Dewhurst, W.G., and Marley, E. (1965). Action of sympathomimetic and allied amines on the central nervous system of the chicken.Br. J. Pharmacol. 25: 705?727.","journal-title":"Br. J. Pharmacol."},{"key":"CR73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0028-3908(83)90124-7","volume":"22","author":"S.L. Dickinson","year":"1983","unstructured":"Dickinson S.L. and Curzon G. (1983). Roles of dopamine and 5-HT in stereotyped and non-stereotyped behaviour.Neuropharmacol. 22: 805?812.","journal-title":"Neuropharmacol."},{"key":"CR74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.2042-7158.1976.tb04048.x","volume":"28","author":"D.J. Dooley","year":"1976","unstructured":"Dooley, D.J., and Quock, R.M. (1976). Tryptamine and 5-hydroxytryptamine induced hypothermia in mice.J. Pharm. Pharmacol. 28: 775?776.","journal-title":"J. Pharm. Pharmacol."},{"key":"CR75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4612-5312-9_34","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"C.T. Dourish","year":"1984","unstructured":"Dourish, C.T., and Broadbent, J. (1984). Effects of tryptamine and 5-hydroxytryptamine on food intake in the rat. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 415?421."},{"key":"CR76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0305-0491(89)90086-2","volume":"93","author":"R. Dubbels","year":"1989","unstructured":"Dubbels, R., and Elofsson, R. (1989). N-Acetylation of arylalkylamines (serotonin and tryptamine) in the crayfish brain.Comp. Biochem. Physiol. 93: 307?312.","journal-title":"Comp. Biochem. Physiol."},{"key":"CR77","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1471-4159.1980.tb11267.x","volume":"34","author":"D.A. Durden","year":"1980","unstructured":"Durden, D.A., and Philips, S.R. (1980). Kinetic measurements of the turnover rates of phenylethylamine and tryptaminein vivo in the rat brain.J. Neurochem. 34: 1725?1732.","journal-title":"J. Neurochem."},{"key":"CR78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF00964508","volume":"9","author":"L.E. Dyck","year":"1984","unstructured":"Dyck, L.E. (1984). Tryptamine transport in rat brain slices: A comparison with 5-hydroxytryptamine.Neurochem. Res. 9: 617?628.","journal-title":"Neurochem. Res."},{"key":"CR79","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0024-3205(89)90309-3","volume":"44","author":"L.E. Dyck","year":"1989","unstructured":"Dyck, L.E. (1989). Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.Life Sci. 44: 1149?1156.","journal-title":"Life Sci."},{"key":"CR80","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/197502a0","volume":"197","author":"D. Eccleston","year":"1963","unstructured":"Eccleston, D., Crawford, T.B.B., and Ashcroft, G. (1963). Tryptamine in the blood and urine of a patient with a carcinoid tumour.Nature 197: 502?503.","journal-title":"Nature"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0028-3908(82)90208-8","volume":"21","author":"C. Ennis","year":"1982","unstructured":"Ennis, C., and Cox, B. (1982). Pharmacological evidence for the existence of two distinct serotonin receptors in rat brain.Neuropharmacol. 21: 41?44.","journal-title":"Neuropharmacol."},{"key":"CR82","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1471-4159.1981.tb00594.x","volume":"36","author":"C. Ennis","year":"1981","unstructured":"Ennis, C., Kemp, J.D., and Cox, B. (1981). Characterization of inhibitory receptors that modulate dopamine release in the striatum.J. Neurochem. 36: 1515?1520.","journal-title":"J. Neurochem."},{"key":"CR83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00407441","volume":"2","author":"A.M. Ernst","year":"1961","unstructured":"Ernst, A.M., Van-Andel, H., and Charbon, G.A. (1961). Beruht die experimentelle Katatonic durch tryptamin auf einer Verdrangung des 5-hydroxytryptamine?Psychopharm. 2: 425?435.","journal-title":"Psychopharm."},{"key":"CR84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(71)92048-4","volume":"2","author":"J.E. Fischer","year":"1971","unstructured":"Fischer, J.E., and Baldessarini, R.J. (1971). False neurotransmitters and hepatic failure.Lancet 2: 75?80.","journal-title":"Lancet"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-4612-4602-2_24","volume-title":"Trace Amines: Comparative and Clinical Neurobiology","author":"P.J. Fletcher","year":"1988","unstructured":"Fletcher, P.J. (1988). Effects of tryptamine and 5-HT microinjected into the nucleus accumbens on D-amphetamine-locomotor activity. In Boulton A.A., Juorio A.V. and Downer R.G.H. (eds.) Trace Amines: Comparative and Clinical Neurobiology, Humana Press, Clifton, N.J., pp. 273?280."},{"key":"CR86","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0091-3057(89)90057-9","volume":"32","author":"P.J. Fletcher","year":"1989","unstructured":"Fletcher, P.J., and Paterson, I.A. (1989). A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus.Pharmacol. Biochem. Behav. 32: 907?911.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"CR87","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0006-2952(75)90089-1","volume":"24","author":"A. Foldes","year":"1975","unstructured":"Foldes, A., and Costa, E. (1975). Relationship of brain monoamines and locomotor activity in rats.Biochem. Pharmacol. 24: 1617?1621.","journal-title":"Biochem. Pharmacol."},{"key":"CR88","first-page":"126","volume":"21","author":"C.J. Fowler","year":"1984","unstructured":"Fowler, C.J., Magnusson, O., and Ross, S.B. (1984). Intra and extraneuronal monoamine oxidase.Blood Vessels 21: 126?131.","journal-title":"Blood Vessels"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000138364","volume":"36","author":"M.J. Fregly","year":"1988","unstructured":"Fregly, M.J., Lockley, O.E., and Cade, J.R. (1988). Effect of dietary treatment with L-tryptophan on the development of renal hypertension in rats.Pharmacol. 36: 91?100.","journal-title":"Pharmacol."},{"key":"CR90","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF00182720","volume":"337","author":"M. Frenken","year":"1988","unstructured":"Frenken, M., and Kaumann, A. (1988). Effects of tryptamine mediated through 2 states of the 5-HTz receptor in calf coronary artery.Naunyn-Schmiedeberg's Arch. Pharmacol. 337: 484?492.","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR91","unstructured":"Friedman, R.N. (1979). Tryptamine-induced alterations of acetylcholine release at a neuromuscular junction.Soc. Neurosci. Abstr. 5: 480P."},{"key":"CR92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(81)90441-8","volume":"214","author":"R.N. Friedman","year":"1981","unstructured":"Friedman, R.N., Shank, R.P., and Freeman, A.R. (1981). The effects of tryptamine on transmitter release at a lobster neuromuscular junction.Brain Res. 214: 101?111.","journal-title":"Brain Res."},{"key":"CR93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0014-2999(68)90169-6","volume":"4","author":"K. Fuxe","year":"1968","unstructured":"Fuxe, K., and Ungerstedt, U. (1968). Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurones after intraventricular injection of catecholamines and 5-hydroxytryptamine.Eur. J. Pharmacol. 4: 134?144.","journal-title":"Eur. J. Pharmacol."},{"key":"CR94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1113\/jphysiol.1953.sp004851","volume":"119","author":"J.H. Gaddum","year":"1953","unstructured":"Gaddum, J.H. (1953). Tryptamine receptors.J. Physiol. 119: 363?368.","journal-title":"J. Physiol."},{"key":"CR95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00490169","volume":"88","author":"M. Geffard","year":"1987","unstructured":"Geffard, M., Tuffet, S., Mons, N., and Chagnaud, J.L. (1987). Simultaneous detection of indoleamines and dopamine in rat dorsal nuclei using specific antibodies.Histochem. 88: 61?64.","journal-title":"Histochem."},{"key":"CR96","first-page":"430","volume":"45","author":"R. Gerber","year":"1986","unstructured":"Gerber, R., Marien, M.R., and Altar, C.A. (1986). Intra-accumbens tryptamine injections increase rat locomotor activity.Fed. Proc. (Abstr.) 45: 430.","journal-title":"Fed. Proc. (Abstr.)"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1113\/jphysiol.1966.sp008010","volume":"185","author":"H.M. Gerschenfeld","year":"1966","unstructured":"Gerschenfeld, H.M., and Stefani, E. (1966). An electrophysiological study of 5-HT receptors of neurones in the molluscan nervous system.J. Physiol. 185: 684?700.","journal-title":"J. Physiol."},{"key":"CR98","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0024-3205(80)90368-9","volume":"27","author":"S.C. Gershon","year":"1980","unstructured":"Gershon, S.C., and Baldessarini, R.J. (1980). Motor effects of serotonin in the central nervous system.Life Sci. 27: 1435?1451.","journal-title":"Life Sci."},{"key":"CR99","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/2041318a0","volume":"204","author":"J. Glowinski","year":"1964","unstructured":"Glowinski, J., and Axelrod, J. (1964). Inhibition of uptake of Initiated noradrenaline in the intact rat brain by imipramine and structurally related compounds.Nature (Lond.) 204: 1318?1319.","journal-title":"Nature (Lond.)"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0028-3908(85)90153-4","volume":"24","author":"G.M. Goodwin","year":"1985","unstructured":"Goodwin, G.M., De Souza, R.J., and Green, A.R. (1985). The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT).Neuropharmacol. 24: 1187?1194.","journal-title":"Neuropharmacol."},{"key":"CR101","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0028-3908(87)90253-X","volume":"26","author":"D. Graham","year":"1987","unstructured":"Graham, D., and Langer, S.Z. (1987). [3H]Tryptamine binding sites of rat cerebral cortex: Pharmacological profile and plasticity.Neuropharmacology 26: 1093?1097.","journal-title":"Neuropharmacology"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0028-3908(83)90147-8","volume":"22","author":"A.R. Green","year":"1983","unstructured":"Green, A.R., O'Shaughnessy, K., Hammond, M., Schachter, M., and Grahame-Smith, D.G. (1983). Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.Neuropharmacol. 22: 573?578.","journal-title":"Neuropharmacol."},{"key":"CR103","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0361-9230(87)90197-3","volume":"18","author":"A.J. Greenshaw","year":"1987","unstructured":"Greenshaw, A.J., and Dewhurst, W.G. (1987). Tryptamine receptors: Fact, myth or misunderstanding?Brain Res. Bull. 18: 253?256.","journal-title":"Brain Res. Bull."},{"key":"CR104","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1471-4159.1988.tb03086.x","volume":"51","author":"M. Hadjiconstantinou","year":"1988","unstructured":"Hadjiconstantinou, M., Rosetti, Z., Silvia, C.P., Krajnc, D., and Neff, N.H. (1988). Aromatic L-aminoacid decarboxylase activity of the rat retina is modulated in vivo by environmental light.J. Neurochem. 51: 1560?1564.","journal-title":"J. Neurochem."},{"key":"CR105","unstructured":"Hadjiconstantinou, M., Silvia, C.P., Hubble, J.P., Isaacs, L.A., Nemlinger, T.A., and Neff, N.H. (1989). Modulation of striatal aromatic L-aminoacid decarboxylase.Soc. Neurosci. (Abstr.) 15: 1313P."},{"key":"CR106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jlac.19355200112","volume":"520","author":"G. Hahn","year":"1935","unstructured":"Hahn, G., Barwald, L., Schales, O., and Werner, H. (1935). Synthese von tetrahydroharman(4-Carbolin)-Derivaten unter physiologischen Bedingungen.Justus Liebigs Anal Chem. 520: 107?123.","journal-title":"Justus Liebigs Anal Chem."},{"key":"CR107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1476-5381.1967.tb01944.x","volume":"29","author":"R.E. Handschumacher","year":"1967","unstructured":"Handschumacher, R.E., and Vane, R. (1967). The relationship between the penetration of tryptamine and 5-hydroxytryptamine with smooth muscle and the associated contractions.Br. J. Pharmacol. Chemother. 29: 105?118.","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"CR108","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4612-5312-9_18","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"R.E.W. Harrison","year":"1984","unstructured":"Harrison, R.E.W., and Christian, S.T. (1984). Individual housing stress elevates brain and adrenal tryptamine. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 249?256."},{"key":"CR109","doi-asserted-by":"crossref","unstructured":"Hayaishi, O. (1976). Properties and function of the indoleamine 2,3-dioxygenase.J. Biochem. 79: 13P.","DOI":"10.1093\/oxfordjournals.jbchem.a131115"},{"key":"CR110","first-page":"539","volume":"7","author":"R.E. Heikkila","year":"1974","unstructured":"Heikkila, R.E., and Cohen, G. (1974). The inhibition of (3H)-biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.Res. Commun. Chem. Path. Pharmacol. 7: 539?547.","journal-title":"Res. Commun. Chem. Path. Pharmacol."},{"key":"CR111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00410800","volume":"15","author":"E.E. Herkert","year":"1969","unstructured":"Herkert, E.E., and Keup, W. (1969). Excretion patterns of tryptamine, indoleacetic acid and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alphamethyldopa.Psychopharmacol. (Berl.) 15: 48?59.","journal-title":"Psychopharmacol. (Berl.)"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(79)91033-3","volume":"169","author":"F. Hery","year":"1979","unstructured":"Hery, F., Simonnet, G., Bourgoin, S., Soubrie, P., Artaud, F., Hamon, M., and Glowinski, J. (1979). Effect of nerve activity on the in vivo release of [3H]-serotonin continuously formed from L-[3H]-tryptophan in the caudate nucleus of the cat.Brain Res. 169: 317?334.","journal-title":"Brain Res."},{"key":"CR113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01253058","volume":"61","author":"S. Hjorth","year":"1985","unstructured":"Hjorth, S. (1985). Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT.J. Neurol Transm. 61: 131?136.","journal-title":"J. Neurol Transm."},{"key":"CR114","first-page":"474","volume-title":"Advances in Ammonia Metabolism and Hepatic Encephalopathy","author":"E. Holm","year":"1988","unstructured":"Holm, E., Jacob, S., Kortsik, C., Leweling, H., and Fischer, B. (1988). Failure of selective serotonin re-uptake inhibition to worsen the mental state of patients with subclinical hepatic encephalopathy. In Soeters P.B., Wilson J.H.P., Meijer A.J. and Holm E. (eds.) Advances in Ammonia Metabolism and Hepatic Encephalopathy, Elsevier Scientific Publishers, Holland, pp. 474?486."},{"key":"CR115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.1973.tb07533.x","volume":"21","author":"A.S. Horn","year":"1973","unstructured":"Horn, A.S. (1973). Structure-activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by 5-HT and tryptamine analogues.J. Neurochem. 21:883?888.","journal-title":"J. Neurochem."},{"key":"CR116","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj1390645","volume":"139","author":"M.D. Houslay","year":"1974","unstructured":"Houslay, M.D., and Tipton, K.F. (1974). A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.Biochem. J. 139: 645?652.","journal-title":"Biochem. J."},{"key":"CR117","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0021-9258(19)77149-X","volume":"245","author":"A. Ichyama","year":"1970","unstructured":"Ichyama, A., Nakamura, S., Nishizuka, Y., and Hayaishi, O. (1970). Enzymatic studies on the biosynthesis of 5HT in mammalian brain.J. Biol. Chem. 245: 1699?1709.","journal-title":"J. Biol. Chem."},{"key":"CR118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4612-5312-9_35","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"J. Irons","year":"1984","unstructured":"Irons, J., Robinson, C.M., and Marsden, C.A. (1984). 5-HT involvement in tryptamine induced behaviour in mice. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 423?427."},{"key":"CR119","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/newbio243269a0","volume":"243","author":"L. Isaacs","year":"1975","unstructured":"Isaacs, L. (1975). Temperature alteration of monoamine metabolites in cerebrospinal fluid.Nature (New Biol.) 243: 269?271.","journal-title":"Nature (New Biol.)"},{"key":"CR120","first-page":"183","volume-title":"Serotonin in Body Temperature Regulation, Drug Effects and Therapeutic Implications","author":"J.J. Jacob","year":"1979","unstructured":"Jacob, J.J., and Girault, J.M. (1979). Serotonin in Body Temperature Regulation, Drug Effects and Therapeutic Implications (Eds. Lomax P. and Schombaum E.), Marcel Dekker, New York, pp. 183?230."},{"key":"CR121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0024-3205(76)90303-9","volume":"19","author":"B.L. Jacobs","year":"1976","unstructured":"Jacobs, B.L. (1976). An animal behaviour model for studying central serotonergic synapses.Life Sci. 19: 777?786.","journal-title":"Life Sci."},{"key":"CR122","first-page":"387","volume-title":"Handbook of Chemical Neuroanatomy, vol. 2; Classical Transmitters in the CNS","author":"C.B. Jaeger","year":"1984","unstructured":"Jaeger, C.B., Ruggiero, D.A., Albert, V.R., Joh, T.H., and Reis, D.J. (1984a). Immunocytochemical localization of aromatic-1-amino acid decarboxylase. In Bj\u00f6rklund A. and Hokfelt T. (eds.) Handbook of Chemical Neuroanatomy, vol. 2; Classical Transmitters in the CNS, Part 1, Elsevier, Amsterdam, pp. 387?408."},{"key":"CR123","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(84)90053-8","volume":"11","author":"C.B. Jaeger","year":"1984","unstructured":"Jaeger, C.B., Ruggiero, D.A., Albert, V.R., Park, D.H., Joh, T.H., and Reis, D.J. (1984b). Aromatic L-amino acid decarboxylase in the rat brain: Immunocytochemical localization in neurons of the brain stem.Neurosci. 11: 691?713.","journal-title":"Neurosci."},{"key":"CR124","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.6131537","volume":"219","author":"C.B. Jaeger","year":"1983","unstructured":"Jaeger, C.B., Teitelman, G., Joh, T.H., Albert, V.R., Park, D.H., and Reis, D.J. (1983). Some neurons of the rat central nervous system contain aromatic L-amino acid decarboxylase but not monoamines.Science 219:1233?1235.","journal-title":"Science"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01252022","volume":"41","author":"K. Jellinger","year":"1977","unstructured":"Jellinger, K., and Riederer, P. (1977). Brain monoamines in metabolic (endotoxic) coma: a preliminary biochemical study in human post-mortem material.J. Neural Transm. 41: 275?286.","journal-title":"J. Neural Transm."},{"key":"CR126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-3002(62)90494-8","volume":"62","author":"J.B. Jepson","year":"1962","unstructured":"Jepson, J.B., Zaltzman, P., and Udenfriend, S. (1962). Microsomal hydroxylation of tryptamine, indoleacetic acid and related compounds to 6-hydroxy derivatives.Biochem. Biophys. Acta 62: 91?102.","journal-title":"Biochem. Biophys. Acta"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1476-5381.1981.tb10447.x","volume":"73","author":"R.S.G. Jones","year":"1981","unstructured":"Jones, R.S.G. (1981).In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine.Br. J. Pharmacol. 73: 485?493.","journal-title":"Br. J. Pharmacol."},{"key":"CR128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0028-3908(82)90189-7","volume":"21","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G. (1982a). A comparison of the responses of cortical neurones to iontophoretically applied tryptamine and 5-hydroxytryptamine in the rat.Neuropharmacol. 21: 209?214.","journal-title":"Neuropharmacol."},{"key":"CR129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0028-3908(82)90041-7","volume":"21","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G. (1982b). Responses of cortical neurones to stimulation of the nucleus raph\u00e9 medianus: A pharmacological analysis of the role of indoleamines.Neuropharmacol. 21: 511?520.","journal-title":"Neuropharmacol."},{"key":"CR130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0361-9230(82)90079-X","volume":"8","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G. (1982c). Tryptamine modifies cortical neurone responses evoked by stimulation of nucleus raph\u00e9 medianus.Brain Res. Bull. 8: 435?437.","journal-title":"Brain Res. Bull."},{"key":"CR131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0301-0082(82)90023-5","volume":"19","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G. (1982d). Tryptamine: A neuromodulator or neurotransmitter in mammalian brain?.Prog. Neurobiol. 19: 117?139.","journal-title":"Prog. Neurobiol."},{"key":"CR132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4612-5312-9_28","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioural and Clinical Aspects","author":"R.S.G. Jones","year":"1984","unstructured":"Jones, R.S.G. (1984). Trace amine-peptide interactions on central neurons: 1. Tryptamine and substance P. In Boulton A.A., Baker G.B. Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioural and Clinical Aspects, Humana Press, Clifton, N.J., pp. 321?326."},{"key":"CR133","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/0024-3205(80)90429-4","volume":"27","author":"R.S.G. Jones","year":"1981","unstructured":"Jones, R.S.G., and Boulton, A.A. (1981). Tryptamine and 5-hydroxytryptamine's actions and interactions on cortical neurones in the rat.Life Sci. 27: 1849?1856.","journal-title":"Life Sci."},{"key":"CR134","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0014-2999(82)90361-2","volume":"81","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G., and Broadbent, J. (1982a). Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raph\u00e9 medianus.Eur. J. Pharmacol. 81: 681?685.","journal-title":"Eur. J. Pharmacol."},{"key":"CR135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0028-3908(82)90132-0","volume":"21","author":"R.S.G. Jones","year":"1982","unstructured":"Jones, R.S.G., and Broadbent, J. (1982b). Further studies on the role of indoleamines in responses of cortical neurones evoked by stimulation of the nucleus raph\u00e9 medianus: The effects of precursor loading.Neuropharmacol. 21: 1273?1278.","journal-title":"Neuropharmacol."},{"key":"CR136","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1139\/y82-054","volume":"60","author":"A.V. Juorio","year":"1982","unstructured":"Juorio, A.V. (1982). The effects of some antipsychotic drugs, D-amphetamine and reserpine in the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.Can. J. Physiol. Pharmacol. 60: 376?380.","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"CR137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4612-5312-9_13","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"A.V. Juorio","year":"1984","unstructured":"Juorio, A.V. (1984). Drug-induced changes in the central metabolism of tyramine and other trace monoamines: their possible role in brain functions. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 145?162."},{"key":"CR138","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/BF00973040","volume":"9","author":"A.V. Juorio","year":"1984","unstructured":"Juorio, A.V., and Durden, D.A. (1984). The distribution and turnover of tryptamine in the brain and spinal cord.Neurochem. Res. 9: 1283?1293.","journal-title":"Neurochem. Res."},{"key":"CR139","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1471-4159.1985.tb04004.x","volume":"45","author":"A.V. Juorio","year":"1985","unstructured":"Juorio, A.V., and Greenshaw, A.J. (1985). Tryptamine concentrations in areas of 5-hydroxytryptamine terminal innervation after electrolytic lesions of midbrain raph\u00e9 nuclei.J. Neurochem. 45: 422?426.","journal-title":"J. Neurochem."},{"key":"CR140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0006-8993(86)90381-1","volume":"371","author":"A.V. Juorio","year":"1986","unstructured":"Juorio, A.V., and Greenshaw, A.J. (1986). Tryptamine depletion in the rat striatum following electrolytic lesions of the substantia nigra.Brain Res. 371: 386?389.","journal-title":"Brain Res."},{"key":"CR141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0306-3623(90)91005-C","volume":"21","author":"A.V. Juorio","year":"1990","unstructured":"Juorio, A.V., and Paterson, I.A. (1990). Tryptamine may couple dopaminergic and serotonergic transmission in the brain.Gen. Pharmacol. 21: 613?616.","journal-title":"Gen. Pharmacol."},{"key":"CR142","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1471-4159.1987.tb05669.x","volume":"48","author":"A.V. Juorio","year":"1987","unstructured":"Juorio, A.V., Greenshaw, A.J., and Nguyen, T.V. (1987a). Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.J. Neurochem. 48: 1346?1350.","journal-title":"J. Neurochem."},{"key":"CR143","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0306-3623(90)91030-U","volume":"21","author":"A.V. Juorio","year":"1990","unstructured":"Juorio, A.V., Li, X.M., and Boulton, A.A. (1990). The effects of chronic trimipramine treatment on biogenic amine metabolism and on dopamine D2, 5-HT2 and tryptamine binding sites in rat brain.Gen. Pharmacol. 21: 759?762.","journal-title":"Gen. Pharmacol."},{"key":"CR144","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-8993(87)90440-9","volume":"426","author":"A.V. Juorio","year":"1987","unstructured":"Juorio, A.V., Walz, W., and Sloley, B.D. (1987b). Absence of decarboxylation of some aromatic-L-amino acids by cultured astrocytes.Brain Res. 426: 183?186.","journal-title":"Brain Res."},{"key":"CR145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0024-3205(86)90428-5","volume":"38","author":"A. Karasawa","year":"1986","unstructured":"Karasawa, A., Serikyaku, S., and Ishitani, R. (1986). Temperature-sensitive high affinity [3H]tryptamine binding sites in rat brain.Life Sci. 38: 1331?1337.","journal-title":"Life Sci."},{"key":"CR146","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-8993(86)91282-5","volume":"366","author":"P. Kaulen","year":"1986","unstructured":"Kaulen, P., Br\u00fcning, G., Rommelspacher, H., and Baumgarten, H.G. (1986). Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain.Brain Res. 366: 72?88.","journal-title":"Brain Res."},{"key":"CR147","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0014-2999(82)90492-7","volume":"78","author":"K.J. Kellar","year":"1982","unstructured":"Kellar, K.J., and Cascio, C.S. (1982). [3H]Tryptamine: high affinity binding sites in rat brain.Eur. J. Pharmacol. 78: 475?478.","journal-title":"Eur. J. Pharmacol."},{"key":"CR148","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/0-89603-078-4:119","volume-title":"Neuromethods vol. 4: Receptor Binding","author":"K.J. Kellar","year":"1986","unstructured":"Kellar, K.J., and Cascio, C.S. (1986). Tryptamine and phenylethylamine recognition sites in brain. In Boulton A.A., Baker G.B. and Hrdina P.D. (eds.) Neuromethods vol. 4: Receptor Binding, Humana Press, Clifton, N.J., pp. 119?137."},{"key":"CR149","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-1-4612-5312-9_50","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"E. Kienzl","year":"1984","unstructured":"Kienzl, E., Riederer, P., Jellinger, K., and Noller, H. (1984).14C-Tryptamine binding in Parkinson's disease and hepatic coma. In Boulton A.A., Baker G.B., Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 571?580."},{"key":"CR150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/978-1-4612-5010-4_47","volume-title":"Neuropsychopharmacology of the Trace Amines","author":"E. Kienzl","year":"1985","unstructured":"Kienzl, E., Riederer, P., Jellinger, K., and Noller, H. (1985). A physicochemical approach to characterise [3H]tryptamine binding sites in human brain. In Boulton A.A., Bieck P.R., Maitre L. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines, Humana Press, Clifton, N.J., pp. 469?485."},{"key":"CR151","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00404952","volume":"13","author":"D.F. Klein","year":"1968","unstructured":"Klein, D.F. (1968). Psychiatric diagnosis and typology of clinical drug effects.Psychopharmacol. 13: 359?386.","journal-title":"Psychopharmacol."},{"key":"CR152","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.1.5907.549","volume":"1","author":"A.J. Knell","year":"1974","unstructured":"Knell, A.J., Davidson, A.R., Williams, R., Kantamanemi, B.D., and Curzon, G. (1974). Dopamine and serotonin metabolism in hepatic encephalopathy.Brit. Med. J. 1: 549?551.","journal-title":"Brit. Med. J."},{"key":"CR153","first-page":"109","volume":"11","author":"P.J. Knott","year":"1974","unstructured":"Knott P.J., Marsden C.A. and Curzon G. (1974). Comparative studies of brain 5HT and tryptamine.Adv. Biochem. Psychopharmacol. 11: 109?114.","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"CR154","first-page":"471","volume":"20","author":"K. Krnjevic","year":"1963","unstructured":"Krnjevic, K., and Phillis, J.W. (1963). Actions of certain amines on cerebral cortical neurones.Br. J. Pharmacol. 20: 471?490.","journal-title":"Br. J. Pharmacol."},{"key":"CR155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/217136a0","volume":"217","author":"P.A. Kuehl","year":"1968","unstructured":"Kuehl, P.A., VandenHeuvel, W.J.A., and Ormond, R.E. (1968). Urinary metabolites in Parkinson's Disease.Nature 217: 471?490.","journal-title":"Nature"},{"key":"CR156","first-page":"1135","volume":"87","author":"R. Kuhn","year":"1957","unstructured":"Kuhn, R. (1957). \u00dcber die Behandlung depressiver Zustande mit einem Iminodibenzylderivat (G 22355).Schweiz. Med. Wockenschr. 87: 1135?1140.","journal-title":"Schweiz. Med. Wockenschr."},{"key":"CR157","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0278-5846(87)90067-4","volume":"11","author":"S. Lal","year":"1987","unstructured":"Lal, S., Quirion, R., Fafaille, F., Nair, N.P.V., Loo, P., Braunwalder, A., Wood, P., and Williams, M. (1987). Muscarinic, benzodiazepine, GABA, chloride channel and other binding sites in frontal cortex in hepatic coma in man.Prog. Neuro-Psychopharmacol. Biol. Psychiat. 11: 243?250.","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiat."},{"key":"CR158","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0006-8993(83)91339-2","volume":"265","author":"A.A. Larson","year":"1983","unstructured":"Larson, A.A. (1983). Hyperalgesia produced by the intrathecal administration of tryptamine to rats.Brain Res. 265: 109?117.","journal-title":"Brain Res."},{"key":"CR159","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4612-5010-4_24","volume-title":"Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects","author":"A.A. Larson","year":"1985","unstructured":"Larson, A.A. (1985). Distribution of CNS sites sensitive to tryptamine and serotonin in pain processing. In Boulton A.A., Bieck P.R., Maitre L. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects, Humana Press, Clifton, N.J., pp. 241?250."},{"key":"CR160","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0028-3908(84)90082-0","volume":"23","author":"A.A. Larson","year":"1984","unstructured":"Larson, A.A., and Wilcox, G.L. (1984). Synergistic behavioural effects of serotonin and tryptamine injected intrathecally in mice.Neuropharmacol. 23: 1415?1418.","journal-title":"Neuropharmacol."},{"key":"CR161","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1210\/jcem-22-12-1242","volume":"22","author":"R.J. Levine","year":"1962","unstructured":"Levine, R.J., Oates, J.A., Vendsalu, A., and Sjoerdsma, A. (1962). Studies on the metabolism of aromatic amines in relation to altered thyroid function in man.J. Clin. Endocrinol. Metab. 22: 1242?1250.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR162","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/272168a0","volume":"272","author":"J.E. Leysen","year":"1978","unstructured":"Leysen, J.E., Niemegeers, C.J.E., Tollenaere, J.P., and Laduron, P.M. (1978). Serotonergic component of neuroleptic receptors.Nature 272: 163?166.","journal-title":"Nature"},{"key":"CR163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4612-5010-4_18","volume-title":"Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects","author":"R.A. Locock","year":"1985","unstructured":"Locock, R.A., Baker, G.B., Coutts, R.T., Dewhurst, W.G., and Liu, T.T.S. (1985). Interaction of trace amines with serotonin recognition sites in rat brain. In Boulton A.A., Bieck P.R., Maitre L. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects, Humana Press, Clifton, N.J., pp. 195?200."},{"key":"CR164","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0028-3908(82)90130-7","volume":"21","author":"G. Luscombe","year":"1982","unstructured":"Luscombe, G., Jenner, P., and Marsden, C.D. (1982). Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.Neuropharmacol. 21: 1257?1265.","journal-title":"Neuropharmacol."},{"key":"CR165","first-page":"85","volume":"230","author":"A.J. Mandell","year":"1971","unstructured":"Mandell, A.J., and Morgan, M. (1971). Indole(ethyl)amine N-methyltransferase in human brain.Nature 230: 85.","journal-title":"Nature"},{"key":"CR166","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1126\/science.133.3467.1832","volume":"133","author":"A.J. Mandell","year":"1961","unstructured":"Mandell, A.J., Slater, G.G., and Mersol, I. (1961). Indole-like urinary stress reactant in man.Science 133: 1832.","journal-title":"Science"},{"key":"CR167","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/0028-3908(87)90167-5","volume":"26","author":"M.R. Marien","year":"1987","unstructured":"Marien, M.R., Gerber, R., Boyar, W.C., and Altar, C.A. (1987). Injections of deuterated tryptamine into the nucleus accumbens of the rat: Effects on locomotor activity and monoamine metabolism.Neuropharmacol. 26: 1481?1488.","journal-title":"Neuropharmacol."},{"key":"CR168","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1476-5381.1975.tb07349.x","volume":"53","author":"E. Marley","year":"1975","unstructured":"Marley, E., and Nitisco, G. (1975). Tryptamines and some other substances affecting waking and sleep in fowls.Br. J. Pharmacol. 53: 193?205.","journal-title":"Br. J. Pharmacol."},{"key":"CR169","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1974.tb12214.x","volume":"23","author":"C.A. Marsden","year":"1974","unstructured":"Marsden, C.A., and Curzon, G. (1974). Effects of lesions and drugs on brain tryptamine.J. Neurochem. 23: 1171?1176.","journal-title":"J. Neurochem."},{"key":"CR170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0028-3908(79)90056-X","volume":"18","author":"C.A. Marsden","year":"1979","unstructured":"Marsden, C.A., and Curzon, G. (1979). The role of tryptamine in the behavioural effects of tranylcypromine+L-tryptophan.Neuropharmacol. 18: 159?164.","journal-title":"Neuropharmacol."},{"key":"CR171","first-page":"96","volume-title":"Trace Amines: Comparative and Clinical Neurobiology","author":"L.L. Martin","year":"1988","unstructured":"Martin, L.L., Baker, G.B., and Wood, P.L. (1988). Tryptamine turnover: Effects of drugs. In Boulton A.A., Juorio A.V. and Downer R.G.H. (eds.) Trace Amines: Comparative and Clinical Neurobiology, Humana Press, Cliton, N.J., pp. 96?104."},{"key":"CR172","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0006-8993(87)90589-0","volume":"419","author":"L.L. Martin","year":"1987","unstructured":"Martin, L.L., Neale, R.F., and Wood, P.L. (1987). Down-regulation of tryptamine receptors following chronic administration of clorgyline.Brain Res. 419: 239?243.","journal-title":"Brain Res."},{"key":"CR173","first-page":"135","volume":"26","author":"L.L. Martin","year":"1984","unstructured":"Martin, L.L., Roland, D.M., Neale, R.F., and Wood, P.L. (1984).3H-Tryptamine binding in rat brain: Effects of phenylalkylamine derivatives.Pharmacologist 26: 135.","journal-title":"Pharmacologist"},{"key":"CR174","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1523\/JNEUROSCI.06-01-00094.1986","volume":"6","author":"J.K. McCormack","year":"1986","unstructured":"McCormack, J.K., Bietz, A.J., and Larson, A.A. (1986). Autoradiographic localisation of tryptamine binding sites in the rat and dog central nervous system.J. Neurosci. 6: 94?101.","journal-title":"J. Neurosci."},{"key":"CR175","first-page":"362","volume-title":"Molecular Neurobiology of the Mammalian Brain","year":"1979","unstructured":"McGeer, P.L., Eccles, Sir J.C., and McGeer, E.G. (Eds.) (1979). Molecular Neurobiology of the Mammalian Brain, Plenum Press, New York, p. 362."},{"key":"CR176","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1471-4159.1970.tb11387.x","volume":"17","author":"J.L. Meek","year":"1970","unstructured":"Meek, J.L., Krall, A.R., and Lipton, M.A. (1970). Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine, and norepinephrine.J. Neurochem. 17: 1627?1635.","journal-title":"J. Neurochem."},{"key":"CR177","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00414413","volume":"23","author":"K. Modigh","year":"1972","unstructured":"Modigh, K. (1972). Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice.Psychopharmacol. 23: 48?54.","journal-title":"Psychopharmacol."},{"key":"CR178","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.1986.tb13052.x","volume":"46","author":"F. Moroni","year":"1986","unstructured":"Moroni, F., Lombardi, G., Carl\u00e0, V., Pellegrini, D., Carassale, G.L., and Cortesini, C. (1986). Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.J. Neurochem. 46: 869?874.","journal-title":"J. Neurochem."},{"key":"CR179","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-2952(82)90234-9","volume":"31","author":"I. Mounsey","year":"1982","unstructured":"Mounsey, I., Brady, K.A., Carroll, J., Fisher, R., and Middlemiss, D.N. (1982). K+-evoked [3H]-5-HT release from rat frontal cortex slices: The effect of 5-HT agonists and antagonists.Biochem. Pharmacol. 31: 49?53.","journal-title":"Biochem. Pharmacol."},{"key":"CR180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00712985","volume":"13","author":"D.D. Mousseau","year":"1993","unstructured":"Mousseau, D.D., McManus, D.J., Baker, G.B., Juorio, A.V., Dewhurst, W.G., and Greenshaw, A.J. (1993). Effects of age and of chronic antidepressant treatment on [3H]-tryptamine binding to rat cortical membranes.Cell. Molec. Neurobiol. 13: 3?13.","journal-title":"Cell. Molec. Neurobiol."},{"key":"CR181","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-4612-5010-4_36","volume-title":"Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects","author":"D.L. Murphy","year":"1985","unstructured":"Murphy, D.L., Tamarkin, L., Garrick, N.A., Taylor, P.L., and Markey, S.P. (1985). Trace indoleamines in the central nervous system. In Boulton A.A., Bieck P.R., Maitre L. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects, Humana Press, Clifton, N.J., pp. 343?360."},{"key":"CR182","unstructured":"Namboodiri, M.A.A., Dubbels, R., and Klein, D.C. (1987). Purification of pineal arylalkylamine N-acetyltransferase (mammalian pineal gland). In Kaufmann S. (ed.) Methods in Enzymology, vol. 142, pp. 583?590."},{"key":"CR183","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/0024-3205(74)90089-7","volume":"14","author":"N.H. Neff","year":"1974","unstructured":"Neff, N.H., and Yang, H.-Y.T. (1974). Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.Life Sci. 14: 2061?2074.","journal-title":"Life Sci."},{"key":"CR184","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00711411","volume":"9","author":"T.V. Nguyen","year":"1989","unstructured":"Nguyen, T.V., and Juorio, A.V. (1989a). Binding sites for brain trace amines.Cell. Molec. Neurobiol. 9: 297?311.","journal-title":"Cell. Molec. Neurobiol."},{"key":"CR185","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00167036","volume":"340","author":"T.V. Nguyen","year":"1989","unstructured":"Nguyen, T.V., and Juorio, A.V. (1989b). Down-regulation of tryptamine binding sites following chronic molindone administration.Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 366?371.","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR186","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-8993(89)91539-4","volume":"476","author":"T.V. Nguyen","year":"1989","unstructured":"Nguyen, T.V., Paterson, I.A., Juorio, A.V., Greenshaw, A.J., and Boulton, A.A. (1989). Tryptamine receptors: Neurochemical and electrophysiological evidence for postsynaptic and functional binding sites.Brain Res. 476: 85?93.","journal-title":"Brain Res."},{"key":"CR187","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3181\/00379727-136-35270","volume":"136","author":"W.H. Oldendorf","year":"1971","unstructured":"Oldendorf, W.H. (1971). Brain uptake of radiolabeled essential amino acids by brain following arterial injection.Proc. Soc. Exptl. Biol. Med. 136: 385?386.","journal-title":"Proc. Soc. Exptl. Biol. Med."},{"key":"CR188","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-8993(76)90024-X","volume":"113","author":"W.H. Oldendorf","year":"1976","unstructured":"Oldendorf, W.H., and Braun, L.D. (1976). [3H]-Tryptamine and [3H]-water as diffusible internal standards for measuring brain extraction of radio-labeled substances following carotid injection.Brain Res. 113: 219?224.","journal-title":"Brain Res."},{"key":"CR189","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1983.tb01518.x","volume":"95","author":"L. Oreland","year":"1983","unstructured":"Oreland, L., Arai, Y., and Stenstrom, A. (1983). The effect of deprenyl (seliginine) on intra- and extraneuronal dopamine oxidation.Acta Neurol. Scand. (Suppl) 95: 81?85.","journal-title":"Acta Neurol. Scand. (Suppl)"},{"key":"CR190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00498511","volume":"321","author":"R.S. Ortmann","year":"1982","unstructured":"Ortmann, R.S., Bischoff, S., Radeke, E., Beuch, O., and Delini-Stula, A. (1982). Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers.Naunyn-Schmiedeberg's Arch. Pharmacol. 321: 265?270.","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR191","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-4835(80)90088-3","volume":"31","author":"N.N. Osborne","year":"1980","unstructured":"Osborne, N.N. (1980). Specificity of serotonin uptake by bovine retina: Comparison with tryptamine.Exp. Eye Res. 31: 31?39.","journal-title":"Exp. Eye Res."},{"key":"CR192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4612-4602-2_21","volume-title":"Trace Amines: Comparative and Clinical Neurobiology","author":"N.N. Osborne","year":"1988","unstructured":"Osborne, N.N., and Hogben, M. (1988). The effects of various indoles on the stimulation of inositol phosphate formation in rat cortical slices. In Boulton A.A., Juorio A.V. and Downer R.G.H. (eds.) Trace Amines: Comparative and Clinical Neurobiology, Humana Press, Clifton, N.J., pp. 251?260."},{"key":"CR193","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/BF00965771","volume":"11","author":"N.N. Osborne","year":"1986","unstructured":"Osborne, N.N., Cutcliffe, N., and Peard, A. (1986). Trace amines (ethylamine, octopamine, and tryptamine) stimulate inositol phospholipid hydrolysis in rat cerebral cortex slices.Neurochem. Res. 11: 1525?1531.","journal-title":"Neurochem. Res."},{"key":"CR194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000122649","volume":"23","author":"S.F. Pang","year":"1977","unstructured":"Pang, S.F., Brown, G.M., Grota, L.J., Chambers, J.W., and Rodman, R.L. (1977). Determination of N-acetylserotonin and melatonin activities in the pineal gland, retina, Harderian gland, brain and serum of rats and chickens.Neuroendocrinol. 23: 1?13.","journal-title":"Neuroendocrinol."},{"key":"CR195","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1471-4159.1990.tb05764.x","volume":"55","author":"I.A. Paterson","year":"1990","unstructured":"Paterson, I.A., Juorio, A.V., and Boulton, A.A. (1990). 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system?J.Neurochem. 55: 1827?1837.","journal-title":"J.Neurochem."},{"key":"CR196","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1471-4159.1988.tb01122.x","volume":"51","author":"D.C. Perry","year":"1988","unstructured":"Perry, D.C., Grimm, L.J., Kettler, K.G., and Kellar, K.J. (1988). [3H]Tryptamine binding sites are not identical to monoamine oxidase in rat brain.J. Neurochem. 51: 1535?1540.","journal-title":"J. Neurochem."},{"key":"CR197","first-page":"548","volume":"236","author":"D.C. Perry","year":"1986","unstructured":"Perry, D.C. (1986). [3H]Tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.J. Pharmacol. Exp. Therap. 236: 548?559.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR198","first-page":"783","volume":"8","author":"D.C. Perry","year":"1982","unstructured":"Perry, D.C., Manning, D.C., and Snyder, S.H. (1982).In vivo autoradiographic localisation of [3H]tryptamine binding sites in rat brain.Soc. Neurosci. Abstr. 8: 783.","journal-title":"Soc. Neurosci. Abstr."},{"key":"CR199","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.136.3519.879","volume":"136","author":"T.L. Perry","year":"1962","unstructured":"Perry, T.L. (1962). Urinary excretion of amines in phenylketonuria and Mongolism.Science 136: 879?890.","journal-title":"Science"},{"key":"CR200","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0731-7085(88)80097-9","volume":"6","author":"P. Peura","year":"1988","unstructured":"Peura, P., Faull, K.F., and Barchas, J.D. (1988). Determination of tryptamine in rat brain by gas chromatography-mass spectrometry.J. Pharmacol. Biomed. Analysis 6: 821?825.","journal-title":"J. Pharmacol. Biomed. Analysis"},{"key":"CR201","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1471-4159.1989.tb02531.x","volume":"52","author":"P. Peura","year":"1989","unstructured":"Peura, P., Johnson, J.V., Yost, R.A., and Faull, K.F. (1989). Concentrations of tryptoline and methtryptoline in rat brain.J. Neurochem. 52: 847?852.","journal-title":"J. Neurochem."},{"key":"CR202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4612-5312-9_12","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects","author":"S.R. Philips","year":"1984","unstructured":"Philips, S.R. (1984). Analysis of trace amines: endogenous levels and the effects of various drugs on tissue concentrations in the rat. In Boulton A.A., Baker G.B., Dewhurst W.O. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral and Clinical Aspects, Humana Press, Clifton, N.J., pp. 127?144."},{"key":"CR203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1471-4159.1979.tb11718.x","volume":"33","author":"S.R. Philips","year":"1979","unstructured":"Philips, S.R., and Boulton, A.A. (1979). The effect of monoamine oxidase inhibitors on some arylalkylamines in rat striatum.J. Neurochem. 33: 159?167.","journal-title":"J. Neurochem."},{"key":"CR204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01953756","volume":"36","author":"S.R. Philips","year":"1980","unstructured":"Philips, S.R., Baker, G.B., and McKim, H.R. (1980). Effects of tranylcypromine on the concentrations of some trace amines in the diencephalon and hippocampus of the rat.Experientia 36: 241?242.","journal-title":"Experientia"},{"key":"CR205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1139\/o74-068","volume":"52","author":"S.R. Philips","year":"1974","unstructured":"Philips, S.R., Durden, D.A., and Boulton, A.A. (1974). Identification and distribution of tryptamine in the rat.Can. J. Biochem. 52: 447?451.","journal-title":"Can. J. Biochem."},{"key":"CR206","first-page":"51","volume":"13","author":"S.R. Philips","year":"1978","unstructured":"Philips, S.R., Rozdilsky, B., and Boulton, A.A. (1978). Evidence for the presence of m-tyramine, p-tyramine, tryptamine and phenylethylamine in the rat brain and several areas of human brain.Biol. Psychiat. 13: 51?57.","journal-title":"Biol. Psychiat."},{"key":"CR207","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90299-5","volume":"35","author":"A.J.J. Pijnenburg","year":"1976","unstructured":"Pijnenburg, A.J.J., Konig, W.M.M., van der Heyden, J.A.M., and van Rossum, J.M. (1976). Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.Eur. J. Pharmacol. 35: 45?58.","journal-title":"Eur. J. Pharmacol."},{"key":"CR208","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.2042-7158.1978.tb13229.x","volume":"30","author":"R.M. Quock","year":"1978","unstructured":"Quock, R.M., and Weick, B.G. (1978). Tryptamine-induced drug effects insensitive to serotonin antagonists: Evidence of a specific tryptaminergic receptor stimulation?J. Pharm. Pharmacol. 30: 280?283.","journal-title":"J. Pharm. Pharmacol."},{"key":"CR209","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4612-5312-9_20","volume-title":"Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioural and Clinical Aspects","author":"C.M. Robinson","year":"1984","unstructured":"Robinson, C.M., and Marsden, C.A. (1984). Tryptamine-induced changes in endogenous 5-hydroxytryptamine and [3H]-5-HT release from mouse hypothalamic slices. In Boulton A.A., Baker G.B. Dewhurst W.G. and Sandler M. (eds.) Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioural and Clinical Aspects, Humana Press, Clifton, N.J., pp. 265?270."},{"key":"CR210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7742(08)60009-4","volume":"5","author":"R. Rodnight","year":"1961","unstructured":"Rodnight, R. (1961). Body fluid indoles in mental illness.Int. Rev. Neurobiol. 5: 251?292.","journal-title":"Int. Rev. Neurobiol."},{"key":"CR211","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(85)90397-8","volume":"109","author":"H. Rommelspacher","year":"1985","unstructured":"Rommelspacher H., Br\u00fcning G., Susilo R., Nick M. and Hill R. (1985). Pharmacology of harmalan (1-methyl-3,4-dihydro-?-carboline).Eur. J. Pharmacol. 109: 363?371.","journal-title":"Eur. J. Pharmacol."},{"key":"CR212","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1748-1716.1960.tb01958.x","volume":"49","author":"E. Rosengren","year":"1960","unstructured":"Rosengren E. (1960). Are DOPA decarboxylase and 5-hydroxytryptophan decarboxylase individual enzymes?Acta Physiol. Scand. 49: 364?369.","journal-title":"Acta Physiol. Scand."},{"key":"CR213","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0773.1980.tb02453.x","volume":"46","author":"S.B. Ross","year":"1980","unstructured":"Ross, S.B., and Ask, A.-L. (1980). Structural requirements for uptake into serotonergic neurones.Acta Pharmacol. Toxicol. 46: 270?277.","journal-title":"Acta Pharmacol. Toxicol."},{"key":"CR214","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1471-4159.1990.tb02320.x","volume":"54","author":"Z. Rossetti","year":"1990","unstructured":"Rossetti, Z., Silvia, C.P., Krajnc, D., Neff, N.H., and Hadjiconstantinou, M. (1990). Aromatic L-aminoacid decarboxylase is modulated by D1 receptors in the rat retina.J. Neurochem. 54: 787?791.","journal-title":"J. Neurochem."},{"key":"CR215","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.175.4028.1365","volume":"175","author":"J.M. Saavedra","year":"1972","unstructured":"Saavedra, J.M., and Axelrod, J. (1972). Psychomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.Science 175: 1365?1366.","journal-title":"Science"},{"key":"CR216","first-page":"523","volume":"185","author":"J.M. Saavedra","year":"1973","unstructured":"Saavedra, J.M., and Axelrod, J. (1973). Effects of drugs on the tryptamine content of rat tissues.J. Pharmacol. Exp. Therap. 185: 523?529.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR217","first-page":"135","volume":"10","author":"J.M. Saavedra","year":"1974","unstructured":"Saavedra, J.M., and Axelrod, J. (1974). Brain tryptamine and the effects of drugs.Adv. Biochem. Psychopharmacol. 10: 135?139.","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"CR218","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/226868a0","volume":"226","author":"J.M. Saavedra","year":"1970","unstructured":"Saavedra, J.M., Heller, B., and Fischer, E. (1970). Antagonistic effects of tryptamine and ?-phenylethylamine on the behaviour of rodents.Nature 226: 868.","journal-title":"Nature"},{"key":"CR219","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.131.6.695","volume":"131","author":"H.C. Sabelli","year":"1974","unstructured":"Sabelli, H.C., and Mosnaim, A.D. (1974). Phenylethylamine hypothesis of affective disorder.Amer. J. Psychiat. 131: 695?699.","journal-title":"Amer. J. Psychiat."},{"key":"CR220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1254\/jjp.56.413","volume":"56","author":"M. Saito","year":"1991","unstructured":"Saito, M., Seikyaku, S., and Ishitani, R. (1991). Effect of phospholipase A2 on temperature-induced high-affinity [3H]-tryptamine binding sites in rat brain.Japan. J. Pharmacol. 56: 413?419.","journal-title":"Japan. J. Pharmacol."},{"key":"CR221","first-page":"261","volume":"17","author":"R.J. Schain","year":"1961","unstructured":"Schain, R.J. (1961). Some effects of a monoamine oxidase inhibitor upon changes produced by centrally administered monoamines.Br. J. Pharmacol. 17: 261?266.","journal-title":"Br. J. Pharmacol."},{"key":"CR222","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"J.J. Schildkraut","year":"1965","unstructured":"Schildkraut, J.J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence.Amer. J. Psychiat. 122: 509?522.","journal-title":"Amer. J. Psychiat."},{"key":"CR223","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(80)90141-7","volume":"66","author":"P. Seeman","year":"1980","unstructured":"Seeman, P., Westman, K., Coscina, D., and Warsh, J.J. (1980). Serotonin receptors in hippocampus and frontal cortex.Eur. J. Pharmacol. 66: 179?191.","journal-title":"Eur. J. Pharmacol."},{"key":"CR224","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1471-4159.1985.tb05423.x","volume":"44","author":"A. Segonzac","year":"1985","unstructured":"Segonzac, A., Raisman, R., Tateishi, T., Schoemaker, H., Hicks, P.E., and Langer, S.Z. (1985). Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: Possible allosteric interaction.J. Neurochem. 44: 349?356.","journal-title":"J. Neurochem."},{"key":"CR225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00496102","volume":"328","author":"A. Segonzac","year":"1984","unstructured":"Segonzac, A., Tateishi, T., and Langer, S.Z. (1984). Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.Naunyn-Schmiedeberg's Arch. Pharmacol. 328: 33?37.","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0024-3205(88)90684-4","volume":"42","author":"S. Serikyaku","year":"1988","unstructured":"Serikyaku, S., and Ishitani, R. (1988). Glutaraldehyde pretreatment blocks temperature-induced high-affinity [3H]tryptamine binding.Life Sci. 42: 207?214.","journal-title":"Life Sci."},{"key":"CR227","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.1952.03680100015006","volume":"150","author":"I.J. Selikoff","year":"1952","unstructured":"Selikoff, I.J., Robitzek, E.H., and Orenstein, G.G. (1952). Treatment of pulmonary tuberculosis with hydrazine derivatives of isonicotinic acid.J. Amer. Med. Assoc. 150: 973?980.","journal-title":"J. Amer. Med. Assoc."},{"key":"CR228","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1471-4159.1983.tb08026.x","volume":"40","author":"M. Sette","year":"1983","unstructured":"Sette, M., Briley, M.S., and Langer, S.Z. (1983). Complex inhibition of [3H]imipramine binding by serotonin and non-tricyclic serotonin uptake blockers.J. Neurochem. 40: 622?628.","journal-title":"J. Neurochem."},{"key":"CR229","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0031-6989(73)80005-0","volume":"5","author":"N.S. Shah","year":"1973","unstructured":"Shah, N.S., Donald, A.G., and Freed, J.E. (1973). Influence of imipramine, phenothiazines, cations and ATP on accumulation of radiolabeled 5-hydroxytryptamine and tryptamine by rat brain particulate fraction.Pharmacol. Res. Commun. 5: 259?264.","journal-title":"Pharmacol. Res. Commun."},{"key":"CR230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9673(00)81101-2","volume":"123","author":"J.M. Slingsby","year":"1976","unstructured":"Slingsby, J.M., and Boulton, A.A. (1976). Separation and quantitation of some urinary arylalkylamines.J. Chromatogr. 123: 51?56.","journal-title":"J. Chromatogr."},{"key":"CR231","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1471-4159.1975.tb07670.x","volume":"24","author":"J.W. Sloan","year":"1975","unstructured":"Sloan, J.W., Martin, W.R., Clements, T.H., Buchwald, W.F., and Bridges, S.R. (1975). Factors affecting brain and tissue levels of tryptamine: Species, drugs and lesions.J. Neurochem. 24: 523?532.","journal-title":"J. Neurochem."},{"key":"CR232","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/2211261a0","volume":"221","author":"I. Smith","year":"1969","unstructured":"Smith, I. and Kellow, A.H. (1969). Aromatic amines and Parkinson's disease.Nature 221: 1261.","journal-title":"Nature"},{"key":"CR233","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bj1680495","volume":"168","author":"S.A. Smith","year":"1977","unstructured":"Smith, S.A., and Pogson, C.I. (1977). Tryptophan and the control of plasma glucose concentraions in the rat.Biochem. J. 168: 495?501.","journal-title":"Biochem. J."},{"key":"CR234","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1471-4159.1973.tb06013.x","volume":"21","author":"S.R. Snodgrass","year":"1973","unstructured":"Snodgrass, S.R., and Horn, A.S. (1973). An assay procedure for tryptamine in brain and spinal cord using its [3H]-dansyl derivative.J. Neurochem. 21: 687?696.","journal-title":"J. Neurochem."},{"key":"CR235","first-page":"141","volume":"10","author":"S.R. Snodgrass","year":"1974","unstructured":"Snodgrass, S.R., and Iversen, L.L. (1974). Formation and release of3H-tryptamine from3H-tryptophan in rat spinal cord slices.Adv. Biochem. Psychopharmacol. 10: 141?150.","journal-title":"Adv. Biochem. Psychopharmacol."},{"issue":"Suppl.","key":"CR236","first-page":"79","volume":"14","author":"T.L. Sourkes","year":"1978","unstructured":"Sourkes, T.L. (1978). Tryptophan in hepatic coma.J. Neurol Transm. 14 (Suppl.): 79?86.","journal-title":"J. Neurol Transm."},{"key":"CR237","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005053-196309000-00005","volume":"137","author":"H. Sprince","year":"1963","unstructured":"Sprince, H., Parker, C.M., Jamesom, D., and Alexander, F. (1963). Urinary indoles in schizophrenic and psychoneurotic patients after administration of tranylcypromine (Parnate) and methionine or tryptophan.J Nerv. Ment. Dis. 137: 246?251.","journal-title":"J Nerv. Ment. Dis."},{"key":"CR238","first-page":"1","volume-title":"Handbook of Psychopharmacology, vol 14","author":"R.F. Squires","year":"1978","unstructured":"Squires, R.F. (1978). Monoamine oxidase inhibitors: Animal pharmacology. In Iversen L.L., Iversen S.D. and Snyder S.H. (eds.) Handbook of Psychopharmacology, vol 14., Plenum Press, New York, pp. 1?58."},{"key":"CR239","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01253055","volume":"61","author":"A. Stenstr\u00f6m","year":"1985","unstructured":"Stenstr\u00f6m, A., Arai, Y., and Oreland, L. (1985). Intra- and extraneuronal monoamine oxidase-A and -B activities after central axotomy (hemisection) on rats.J. Neurol Transm. 61: 105?113.","journal-title":"J. Neurol Transm."},{"key":"CR240","first-page":"215","volume":"224","author":"J.S. Stollak","year":"1983","unstructured":"Stollak, J.S., and Furchgott, R.F. (1983). Use of selective antagonists for determining the types of receptor mediating the actions of 5-hydroxytryptamine in the isolated rabbit aorta.J. Pharmacol. Exp. Therap. 224: 215?221.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR241","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0006-2952(89)90198-6","volume":"38","author":"M. Strolin-Benedetti","year":"1989","unstructured":"Strolin-Benedetti, M., and Dostert, P. (1989). Monoamine oxidase, brain ageing and degenerative diseases.Biochem. Pharmacol. 38: 555?561.","journal-title":"Biochem. Pharmacol."},{"key":"CR242","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0028-3908(86)90150-4","volume":"25","author":"Y. Sugimoto","year":"1986","unstructured":"Sugimoto, Y., Yamada, J., and Horisaka, K. (1986). Strain differences in the behaviour induced by tryptamine in five strains of mice.Neuropharmacol. 25: 1289?1291.","journal-title":"Neuropharmacol."},{"key":"CR243","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/0006-2952(86)90421-1","volume":"35","author":"J.P. Sullivan","year":"1986","unstructured":"Sullivan, J.P., McDonnell, L., Hardiman, O.M., Farrell, M.A., Philips, J.P., and Tipton, K.F. (1986). The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.Biochem. Pharmacol. 35: 3255?3260.","journal-title":"Biochem. Pharmacol."},{"key":"CR244","first-page":"xxxix","volume":"50","author":"M.X. Sullivan","year":"1922","unstructured":"Sullivan, M.X. (1922). Indolethylamine in the urine of pellagrins.J. Biol. Chem. 50: xxxix.","journal-title":"J. Biol. Chem."},{"key":"CR245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00165039","volume":"335","author":"R. Susilo","year":"1987","unstructured":"Susilo, R., and Rommelspacher, H. (1987). Formation of a ?-carboline (1,2,3,4-tetrahydro-1-methyl-?-carboline-1-carboxylic acid) following intracerebroventricular injection of tryptamine and pyruvic acid.Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 70?76.","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR246","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1471-4159.1988.tb02483.x","volume":"50","author":"R. Susilo","year":"1988","unstructured":"Susilo, R., Damm, H., and Rommelspacher, H. (1988). Formation of a new biogenic aldehyde adduct by incubation of tryptamine with rat brain tissue.J. Neurochem. 50: 1817?1824.","journal-title":"J. Neurochem."},{"key":"CR247","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0006-2952(81)90300-2","volume":"30","author":"O. Suzuki","year":"1981","unstructured":"Suzuki, O., Katsumata, Y., and Oya, M. (1981). Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase.Biochem. Pharmacol. 30: 1353?1358.","journal-title":"Biochem. Pharmacol."},{"key":"CR248","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0091-3057(83)90347-7","volume":"19","author":"K. Svensson","year":"1983","unstructured":"Svensson, K., and Ahlenius, S. (1983). Suppression of exploratory locomotor activity by the local application of dopamine or 1-noradrenaline to the nucleus accumbens of the rat.Pharmacol. Biochem. Behav. 19: 693?699.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"CR249","first-page":"199","volume-title":"Brain 5-HT1A Receptors","author":"K. Svensson","year":"1987","unstructured":"Svensson, K., Larsson, K., Ahlenius, S., Arvidsson, L.E., and Carlsson, A. (1987). Evidence for a facilatory role of central 5-HT in male mouse sexual behaviour. In Dourish C.T., Ahlenius S., and Hutson P.H. (eds.) Brain 5-HT1A Receptors, Ellis Horwood Ltd., Chichester, pp. 199?210."},{"key":"CR250","first-page":"223","volume":"126","author":"D.H. Tedeschi","year":"1959","unstructured":"Tedeschi, D.H., Tedeschi, R.E., and Fellows, E.J. (1959). The effects of tryptamine in the central nervous system, including a pharmacological procedure for evaluation of iproniazid-like drugs.J. Pharmacol. Exp. Therap. 126: 223?232.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR251","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(84)90714-3","volume":"106","author":"M.D. Tricklebank","year":"1984","unstructured":"Tricklebank, M.D., Forler, C., and Fozard, J.R. (1984). The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic system in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.Eur J. Pharmacol. 106: 271?282.","journal-title":"Eur J. Pharmacol."},{"key":"CR252","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archneurpsyc.1959.02340130141020","volume":"81","author":"W.J. Turner","year":"1959","unstructured":"Turner, W.J., and Merlis, S. (1959). Effect of some indolealkylamines on man.Arch. Neurol. Psychiat. 81: 121?129.","journal-title":"Arch. Neurol. Psychiat."},{"key":"CR253","volume-title":"Trace Amines and the Brain","year":"1976","unstructured":"Usdin, E., and Sandler, M. (Eds.) (1976). Trace Amines and the Brain, Marcel Dekker, New York, N.Y."},{"key":"CR254","first-page":"217","volume":"218","author":"J.M. Neuten Van","year":"1981","unstructured":"Van Neuten, J.M., Janssen, P.A.J., Van Beek, J., Xhonneux, R., Verbeuren, T.J., and Vanhoutte, P.M. (1981). Vascular effects of ketanserin (R41468) ? a novel antagonist of 5-HT2 serotonergic receptors.J. Pharmacol. Exp. Therap. 218: 217?230.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR255","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1016\/S0021-9258(18)90600-9","volume":"259","author":"P. Voisin","year":"1984","unstructured":"Voisin, P., Namboodiri, M.A.A., and Klein, D.C. (1984). Arylamine and arylalkylamine N-acetyltransferase in the mammalian pineal gland.J. Biol. Chem. 259: 10913?10918.","journal-title":"J. Biol. Chem."},{"key":"CR256","first-page":"87","volume-title":"Monoamine Oxidase Inhibitors: The State of the Art","author":"P.C. Waldmeier","year":"1981","unstructured":"Waldmeier, P.C., Felner, A.E., and Maitre, L. (1981). Long term effects of selective MAO inhibitors on MAO activity and amine metabolism. In M.B.H. Youdim and E.S. Paykel (eds.) Monoamine Oxidase Inhibitors: The State of the Art, John Wiley and Sons, Chichester, U.K., p. 87?109."},{"key":"CR257","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0378-4347(00)81833-2","volume":"162","author":"R.W. Walker","year":"1979","unstructured":"Walker, R.W., Mandel, L.R., Kleinman, J.E., Gillin, J.C., Wyatt, R.J., and VandenHeuvel, W.J.A. (1979). Improved selective ion monitoring mass-spectrometry assay for the determination of N,N-dimethyltryptamine in human blood utilizing capillary column gas chromatography.J. Chromatogr. 162: 539?546.","journal-title":"J. Chromatogr."},{"key":"CR258","first-page":"1296","volume":"255","author":"M. A. Wallace","year":"1990","unstructured":"Wallace, M. A., and Claro, E. (1990). Comparison of serotonergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.J. Pharmacol. Exp. Therap. 255: 1296?1300.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR259","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1979.tb11046.x","volume":"32","author":"J.J. Warsh","year":"1979","unstructured":"Warsh, J.J., Coscina, D.V., Godse, D.D., and Chan, P.W. (1979). Dependence of brain tryptamine formation on tryptophan availability.J. Neurochem. 32: 1191?1196.","journal-title":"J. Neurochem."},{"key":"CR260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-2944(77)90045-X","volume":"18","author":"J.J. Warsh","year":"1977","unstructured":"Warsh, J.J., Godse, D.D., Stancer, H.C., Chan, P.W., and Coscina, D.V. (1977). Brain tryptamine in rats by a new gas chromatography-mass fragmentographic method.Biochem. Med. 18: 10?20.","journal-title":"Biochem. Med."},{"key":"CR261","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00431851","volume":"56","author":"M. Weinstock","year":"1978","unstructured":"Weinstock, M., Speiser, Z., and Ashkenazi, R. (1978). Changes in brain catecholamine turnover and receptor sensitivity induced by social deprivation in rats.Psychopharmacol. 56: 205?209.","journal-title":"Psychopharmacol."},{"key":"CR262","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9258(18)70339-6","volume":"234","author":"H. Weissbach","year":"1959","unstructured":"Weissbach, H., King, W., Sjoerdsma, A., and Udenfriend, S. (1959). Formation of indole-3-acetic acid and tryptamine in animals.J. Biol. Chem. 234: 81?86.","journal-title":"J. Biol. Chem."},{"key":"CR263","first-page":"26","volume":"131","author":"H. Weissbach","year":"1961","unstructured":"Weissbach, H., Lovenberg, W., Redfield, B.G., and Udenfriend, S. (1961). In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.J. Pharmacol. Exp. Therap. 131: 26?30.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR264","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(82)90333-8","volume":"86","author":"L.P. Wennogle","year":"1983","unstructured":"Wennogle, L.P., and Meyerson, L. (1983). Serotonin modulates the dissociation of [3H]-imipramine from human platelets recognition sites.Eur. J. Pharmacol. 86: 303?307.","journal-title":"Eur. J. Pharmacol."},{"key":"CR265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4899-7321-4_14","volume-title":"Handbook of Neurochemistry, Vol. 2","author":"V.P. Whittaker","year":"1969","unstructured":"Whittaker V.P. (1969). The synaptosome. In Lajtha A. (ed.) Handbook of Neurochemistry, Vol. 2, Plenum Publishing Corp., New York, pp. 327?364."},{"key":"CR266","first-page":"49","volume-title":"Hepatic Encephalopathy and Metabolic Nitrogen Exchange","author":"J. Wiltfang","year":"1991","unstructured":"Wiltfang, J., Thiele, G., Weissenborn, K., Huther, G., Reimer, A., Pogeler, B., Kanzler, H., Schmidt, F.-W., and Wiltfang, A. (1991). Early hepatic encephalopathy, neurophysiological assessment and correlation with biochemical parameters. In Bengtsson F., Jeppson B., Almdal T. and Vilstrup H. (eds.) Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boston, pp. 49?58."},{"key":"CR267","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4612-5010-4_9","volume-title":"Neuropsychopharmacology of the Trace Amines","author":"P.L. Wood","year":"1985","unstructured":"Wood, P.L., Martin, L.L., and Altar, C.A. (1985). [3H]Tryptamine receptors in rat brain. In Boulton A.A., Maitre L., Bieck P.R. and Riederer P. (eds.) Neuropsychopharmacology of the Trace Amines, Humana Press, Clifton, N.J., pp. 101?114."},{"key":"CR268","first-page":"194","volume":"268","author":"P.L. Wood","year":"1984","unstructured":"Wood, P.L., Pilapil, C., LaFaille, F., Nair, N.P.V., and Glennon, R.A. (1984). Unique [3H]tryptamine binding sites in rat brain: Distribution and pharmacology.Arch. Int. Pharmacodyn. 268: 194?201.","journal-title":"Arch. Int. Pharmacodyn."},{"key":"CR269","first-page":"13","volume":"121","author":"D.W. Wooley","year":"1957","unstructured":"Wooley, D.W., and Shaw, E. (1957). Differentiation between receptors for serotonin and tryptamine by means of exquisite sensitivity of antimetabolites.J. Pharmacol. Exp. Therap. 121: 13?17.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"CR270","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1139\/o73-144","volume":"51","author":"P.H. Wu","year":"1973","unstructured":"Wu, P.H., and Boulton, A.A. (1973). Distribution and metabolism of tryptamine in the rat brain.Can. J. Biochem. 51: 1104?1112.","journal-title":"Can. J. Biochem."},{"key":"CR271","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/0006-2952(87)90603-4","volume":"36","author":"J. Xu","year":"1987","unstructured":"Xu, J., and Chuang, D.-M. (1987). Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats.Biochem. Pharmacol. 36: 2353?2358.","journal-title":"Biochem. Pharmacol."},{"key":"CR272","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0028-3908(87)90043-8","volume":"26","author":"J. Yamada","year":"1987","unstructured":"Yamada, J., Sugimoto, Y., and Horikasa, K. (1987a). The behavioural effects of intravenously administered tryptamine in mice.Neuropharmacol. 26: 49?53.","journal-title":"Neuropharmacol."},{"key":"CR273","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(88)90205-1","volume":"154","author":"J. Yamada","year":"1988","unstructured":"Yamada, J., Sugimoto, Y., and Horisaka, K. (1988). The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin in mice.Eur. J. Pharmacol. 154: 299?304.","journal-title":"Eur. J. Pharmacol."},{"key":"CR274","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1254\/jjp.51.421","volume":"51","author":"J. Yamada","year":"1989","unstructured":"Yamada, J., Sugimoto, Y., and Horisaka, K. (1989). The evidence for the involvement of the 5-HT1A receptor in the 5-HT syndrome induced in mice by tryptamine.Japan J. Pharmacol. 51: 421?424.","journal-title":"Japan J. Pharmacol."},{"key":"CR275","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(90)90098-Q","volume":"181","author":"J. Yamada","year":"1990","unstructured":"Yamada, J., Sugimoto, Y., Kimura, I., Takeuchi, N., and Horisaka, K. (1990). The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice.Eur. J. Pharmacol. 181: 319?322.","journal-title":"Eur. J. Pharmacol."},{"key":"CR276","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(88)90338-X","volume":"156","author":"J. Yamada","year":"1988","unstructured":"Yamada, J., Sugimoto, Y., Kimura, I., Takeuchi, N., and Horisaka, K. (1988). The hypoglycemic effect of tryptamine in mice: mediation by 5-HT receptors.Eur. J. Pharmacol. 156: 299?301.","journal-title":"Eur. J. Pharmacol."},{"key":"CR277","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(87)90505-X","volume":"139","author":"J. Yamada","year":"1987","unstructured":"Yamada, J., Wakita, H., Sugimoto, Y., and Horisaka, K. (1987a). Hypothermia induced in mice by intracerebroventricular injection of tryptamine: Involvement of the 5-HT1 receptor.Eur. J. Pharmacol. 139: 117?119","journal-title":"Eur. J. Pharmacol."},{"key":"CR278","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.1980.tb09944.x","volume":"34","author":"S.N. Young","year":"1980","unstructured":"Young, S.N., Anderson, G.M., Gauthier, S., and Purdy, W.C. (1980a). The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.J. Neurochem. 34: 1087?1092.","journal-title":"J. Neurochem."},{"key":"CR279","first-page":"308","volume":"34","author":"S.N. Young","year":"1980","unstructured":"Young, S.N., Anderson, G.M., and Purdy, W.C. (1980b). Indoleamine metabolism in rat brain studied through measurements of tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in cerebrospinal fluid.J. Neurochem. 34: 308?315.","journal-title":"J. Neurochem."},{"key":"CR280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01250597","volume":"47","author":"S.N. Young","year":"1980","unstructured":"Young, S.N., and Lal, S. (1980). CNS tryptamine metabolism in hepatic coma.J. Neural Transm. 47: 153?161.","journal-title":"J. Neural Transm."},{"key":"CR281","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000123961","volume":"39","author":"S.N. Young","year":"1984","unstructured":"Young, S.N., Gauthier, S., Kiely, M.E., Lal, S., and Brown, G.M. (1984). Effect of oral melatonin administration on melatonin, 5-hydroxyindoleacetic acid, indoleacetic acid, and cyclic nucleotides in human cerebrospinal fluid.Neuroendocrin. 39: 87?92.","journal-title":"Neuroendocrin."},{"key":"CR282","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02174413","volume":"8","author":"E.A. Zeller","year":"1952","unstructured":"Zeller, E.A., Barsky, J., Fouts, J.R., Kircheimer, W.F., and Van Orden, L.S. (1952). Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes.Experientia 8: 349?350.","journal-title":"Experientia"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01000528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01000528\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01000528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T03:58:08Z","timestamp":1625371088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,3]]},"references-count":282,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["BF01000528"],"URL":"https:\/\/doi.org\/10.1007\/bf01000528","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,3]]}}}